Brain Metastases
2 competing products in clinical development for Brain Metastases.
Pipeline by Phase
Phase 1/21
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pembrolizumab + Lenvatinib | Eisai | Phase 2 | Recruiting | 42 |
| Abemaciclib + Endocrine therapy | Eli Lilly | Phase 1/2 | Recruiting | 39 |